• 1
    Halsted WS. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June, 1889 to January, 1894. Johns Hopkins Hosp Bull 1894-1895; 4: 297321.
  • 2
    Haagensen CD. Diseases of the Breast. Philadelphia: WB Saunders; 1956.
  • 3
    Greenough RB. Varying degrees of malignancy in cancer of the breast. J Cancer Res 1925; 9: 452463.
  • 4
    UICC Committee on Clinical Stage Classification and Applied Statistics. Clinical Stage Classification and Presentation of Results, Malignant Tumors of the Breast and Larynx. Paris: International Union Against Cancer; 1958.
  • 5
    BeahrsOH, CarrDT, RubinP, eds. Manual for Staging of Cancer. Philadelphia: Lippincott; 1977.
  • 6
    Bland KI, Menck HR, Scott-Conner CE, et al. The National Cancer Data Base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer 1998; 83: 12621273.
  • 7
    Amir H, Azizi MR, Makwaya CK, Jessani S. TNM classification and breast cancer in an African population: a descriptive study. Cent Afr J Med 1997; 43: 357359.
  • 8
    Ben Ahmed S, Aloulou S, Bibi M, et al. Breast cancer prognosis in Tunisian women: analysis of a hospital series of 729 patients. Sante Publique 2002; 14: 231241.
  • 9
    Ikpatt OF, Kuopio T, Ndoma-Egba R, Collan Y. Breast cancer in Nigeria and Fin-land: epidemiological, clinical and histological comparison. Anticancer Res 2002; 22: 30053012.
  • 10
    Vorobiof DA, Sitas F, Vorobiof G. Breast cancer incidence in South Africa. J Clin Oncol 2001; 19: 125S127S.
  • 11
    Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York: Springer; 2002.
  • 12
    FlemingID, CooperJS, HensonDE, et al, eds. AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott-Raven; 1997.
  • 13
    Cady B, Stone MD, Schuler JG, et al. The new era in breast cancer: invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 1996; 131: 301308.
  • 14
    Haagensen C. Diseases of the Breast. Philadelphia: WB Saunders; 1986.
  • 15
    Yarbro JW, Page DL, Fielding JP, et al. American Joint Committee on Cancer Prognostic Factors Consensus Conference. Cancer 1999; 86: 24362446.
  • 16
    Fitzgibbons PL, Page DL, Weaver D, et al. Prognostic factors in breast cancer: College of Amican Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124: 966978.
  • 17
    Bast RC Jr., Ravdin P, Hayes DF, et al. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the Amican Society of Clinical Oncology. J Clin Oncol 2001; 19: 18651878.
  • 18
    SobinLH, WittekindCH, eds. TNM Classification of Malignant Tumours. 6th edition. New York: Wiley-Liss; 2002.
  • 19
    Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer Staging System for Breast Cancer. J Clin Oncol 2002; 20: 36283636.
  • 20
    Singletary SE, Greene FL, Sobin LH. Classification of isolated tumor cells: clarification of the 6th edition of the AJCC Cancer Staging Manual. Cancer 2003; 98: 27402741.
  • 21
    Greene FL, Brierly J, O'Sullivan B, et al. On the use and abuse of X in the TNM classification. Cancer 2005; 103: 647649.
  • 22
    Braun S, Vogl FD, Naume B, et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 2005; 353: 793802.
  • 23
    Cristofanilli M, Hayes DF, Budd T, et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 2005; 23: 14201430.
  • 24
    Van'tVeer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530536.
  • 25
    Van de Vijver MJ, He UD, Van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347: 19992009.
  • 26
    Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004; 351: 28172826.
  • 27
    Singletary SE. A working model for the time sequence of genetic changes in breast tumorigenesis. J Am Coll Surg 2002; 194: 202216.
  • 28
    Al-Hajj M, Wich MS, Benito-Hernandez A, et al. Prospective identification of tu-morigenic breast cancer cells. PNAS 2003; 100: 39833988.